|
||||||||||
No. |
DFBP ID |
AA sequence |
Peptide/Function name |
AA length |
Peptide mass |
Organism/Source
|
Precursor protein |
PubDate |
1 | DFBPANCA0333 | FHG | Anticancer peptide | 3 | 359.39 Da c | Beef sarcoplasmic | Beef sarcoplasmic protein hydrolysates | 2008 |
2 | DFBPANCA0330 | GFHI | Anticancer peptide | 4 | 472.54 Da c | Beef sarcoplasmic | Beef sarcoplasmic protein hydrolysates | 2008 |
3 | DFBPANCA0863 | TSKYR | Anticancer peptide, α137-141 (NKT) | 5 | 653.73 Da c | Bovine and human hemoglobin | Bovine and human hemoglobin | 2023 |
4 | DFBPANCA0331 | DFHINQ | Anticancer peptide | 6 | 772.81 Da c | Beef sarcoplasmic | Beef sarcoplasmic protein hydrolysates | 2008 |
5 | DFBPANCA0332 | GLSDGEWQ | Anticancer peptide | 8 | 890.90 Da c | Beef sarcoplasmic | Beef sarcoplasmic protein hydrolysates | 2008 |
6 | DFBPANCA0067 | GLFDVIKKVASVIGGL | Anticancer peptide, Citropin 1.1 from Australian frog | 16 | 1615.96 Da c | Australian Bell Frog | Granular dorsal gland | 2000 |
7 | DFBPANCA0068 | GLFDVIKKVASVIGGLG | Anticancer peptide, Citropin 1.1 from Australian frog | 17 | 1673.02 Da c | Australian Bell Frog | Granular dorsal gland | 2000 |
8 | DFBPANCA0386 | FIHHIFRGIVHAGRSIGRFLTG | Anticancer peptide, piscidins 3 (P3) | 22 | 2492 Da | Sythesis | Sythesis peptide | 2021 |
9 | DFBPANCA0385 | FFHHIFRGIVHVGKTIHRLVTG | Anticancer peptide, piscidins 1 (P1) | 22 | 2571 Da | Sythesis | Sythesis peptide | 2021 |
10 | DFBPANCA0431 | GIKCRFCCGCCTPGICGVCCRF | Anticancer peptide, Hepcidin 1-5 (TH1-5) | 22 | 2329.95 Da c | Tilapia, Oreochromis mossambicus | Sythesis peptide | 2011 |